- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: August 2018
- Public Summary Document (PSD) August 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) August 2018 PBAC Meeting - Word
Budesonide wth eformoterol – August 2018
BUDESONIDE WITH EFORMOTEROL Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose 120 doses Powder for oral inhalation in breath actuated device contain
Last updated
31 January 2020